Coot, Roel M.
HRN: 15-06-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/09/2025
05/16/2025
IV
500mg Then 250mg
Now Then Q48h
HAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes